Patrick Frost, PhD

Patrick Frost, PhD

Jan 15, 2016

Group 6 Copy 28
2
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

Preventing the Accidental Spread of Genes from GMOs

Pollen from GMO crops can spread foreign genes (transgenes) to non-GMO crops, and even to wild plant species...

So near and yet so far? Investigating bats on the San Juan Islands

What ecological differences among bats on the San Juan Islands predict which ones are most vulnerable to habitat...

Backer Badge Funded